Within hours of the semaglutide patent expiry, a host of Indian pharma companies have rolled out weight-loss drugs at ...

India is set to combat global obesity with affordable, generic versions of weight-loss drugs like Ozempic, following patent ...

A new study explores how the extreme biology of pythons may point to an unexpected path for obesity research. Pythons don’t nibble. They chomp, squeeze, and swallow their prey whole in a meal that can ...

India is set to launch low-cost generic versions of weight-loss injections, addressing global obesity and expanding access to effective treatments in middle-income countries. With the expiration of ...

A molecule found in python blood has shown the ability to reduce appetite and promote weight loss in mice, offering potential for new obesity treatments.Scientists have identified a molecule in the ...

India is poised to shake up the global weight-loss drug market after key patents expired, clearing the way for low-cost generic versions of blockbuster treatments like Ozempic and Wegovy.

This week, we shall be discussing another very important topic, often diagnosed as osteoporosis. This is a condition of ...

Market experts say patent expiry of semaglutide could create an incremental revenue opportunity of over Rs 5,000 crore for generic manufacturers over next 12-15 months across India, Brazil & Canada.

While taking her history and vital signs, Supiano, a geriatrician at the University of Utah, saw one disturbing signal: Her blood pressure was 148/86, above normal despite her taking two medications ...

Known to the public as a judge on a television show, the French bitcoin pioneer wants to win over the masses to the cryptocurrencies that made him wealthy. With the 2027 presidential election ...

A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of ...

FAT-cat tycoons are living millionaire lifestyles by selling vapes – while kids get hooked on their e-cigs and communities are left to count the cost. And two of the richest beneficiaries of the ...